Inscription Capital, LLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 42 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Inscription Capital, LLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,440
-25.5%
12,0000.0%0.01%
-22.2%
Q2 2023$30,120
+43.4%
12,0000.0%0.01%
+50.0%
Q1 2023$21,000
-70.9%
12,000
-29.4%
0.01%
-76.0%
Q4 2022$72,250
+261.2%
17,0000.0%0.02%
+316.7%
Q3 2022$20,000
+17.6%
17,0000.0%0.01%
+100.0%
Q2 2022$17,000
-59.5%
17,0000.0%0.00%
-75.0%
Q1 2022$42,000
-8.7%
17,0000.0%0.01%
-7.7%
Q4 2021$46,000
-45.9%
17,0000.0%0.01%
-51.9%
Q3 2021$85,000
-15.0%
17,0000.0%0.03%
-20.6%
Q1 2021$100,000
+25.0%
17,0000.0%0.03%
+9.7%
Q4 2020$80,000
+37.9%
17,0000.0%0.03%
+19.2%
Q3 2020$58,00017,0000.03%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders